ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Steatosis by PDFF Affects Percent Remnant Liver Regeneration in Living Donors without Impacting on Clinical Outcomes

A. Duarte-Rojo, Q. Qi, K. Chupetlovska, D. R. Jorgensen, A. A. Borhani, A. Furlan, S. Ganesh, A. Humar

University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2020 American Transplant Congress

Abstract number: C-154

Keywords: Image analysis, Living-related liver donors, Risk factors, Safety

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session C: Liver: Living Donors and Partial Grafts

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Steatosis Quantification by MRI PDFF Effectively Identifies Liver Allografts at Low Risk for Recipient Complicationsin Living Donor Liver Transplantation
  • Improved Regeneration of the Remnant Liver After Extended Hepatectomy or Partial Liver Transplantation by Pharmacologic Mobilization of Endogenous Stem Cells in Rats.

*Purpose: Mild steatosis (5-33% of fat) is not expected to affect liver regeneration following partial hepatectomy. Novel methods to assess steatosis, such as proton density fat fraction (PDFF) from MRI provide an accurate and continuous quantification of mild steatosis. We hypothesized that the burden of steatosis could negatively impact liver regeneration even among living donors within the range of mild steatosis by PDFF.

*Methods: Mild steatosis was defined as a PDFF 6.4-17.3%. Preoperative CT-quantified total and remnant liver volumes were compared against follow-up CT volume at 3 months post-donation with % regeneration defined as: 3-month liver volume / baseline liver volume x 100. Apart from demographics, anthropometry and routine chemistry, clinical outcomes were investigated. We used ANCOVA to determine the effect of steatosis on liver regeneration.

*Results: We included 26 living donors with mean age 38±9, male 57%, non-Hispanic white in 96%, and BMI 27±4. Mild steatosis was found in 7 (range of 6.7 to 11.2%). Although there was no difference in % remnant liver between patients with and without steatosis (47±8% and 46±11, p=0.80; respectively), donors with steatosis regenerated to 77±7% and this was lower than what was observed among those without steatosis at 84±8% of baseline (p=0.03). A reduced regenerative capacity was evident for donors with mild steatosis irrespective of the remnant liver volume (Figure). Importantly, there were no episodes of liver failure or deaths identified among donors, and liver chemistry was similar at baseline and 3 months post-donation.

*Conclusions: Although all donors showed 3-month % liver regeneration within the expected range (80±13% from A2ALL), our findings support that mild steatosis, up to a PDFF of 11%, has a negative impact on liver regeneration after living donation. The impact, however, was not thought to be clinically meaningful and this was supported by the lack of abnormalities in liver chemistry and adverse clinical outcomes.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Duarte-Rojo A, Qi Q, Chupetlovska K, Jorgensen DR, Borhani AA, Furlan A, Ganesh S, Humar A. Steatosis by PDFF Affects Percent Remnant Liver Regeneration in Living Donors without Impacting on Clinical Outcomes [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/steatosis-by-pdff-affects-percent-remnant-liver-regeneration-in-living-donors-without-impacting-on-clinical-outcomes/. Accessed March 3, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.